QTRX

Quanterix Corporation

Quanterix is a company that\'s digitizing biomarker analysis with the goal of advancing the science of precision health. The company\'s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix\' technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.

Quanterix Corporation (QTRX) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Growth (C-). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -1.7
EV / EBITDA -1.7
Rev Growth YoY -13.1%
Gross Margin 44.5%
Price Return 3M 0.3%
Price Return 12M -43.9%
Catalyst Signal 0.00
Market Cap $139.1M
TTM Revenue $148.2M
Price / Sales 0.9
ROE -41.7%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) C- (1.9) B- (3.0) B- (3.0) C+ (2.6) C+ (2.7)
2026-11-07 B- (3.0) C (2.2) B- (3.0) B (3.2) C+ (2.7) C+ (2.8)
2026-10-31 B- (3.0) C (2.2) B- (3.0) C (2.3) C+ (2.7) C+ (2.7)
2026-10-24 B- (3.0) C (2.2) B- (3.0) C- (2.0) C+ (2.6) C+ (2.6)
2026-10-17 B- (3.0) C (2.2) B- (3.0) C- (1.9) C+ (2.6) C+ (2.5)
Page 1 of 5